PATHOLOGY
Department
Sahlgrenska University Hospital
Gotemburgo, SueciaPublications in collaboration with researchers from Sahlgrenska University Hospital (6)
2021
-
Frequency and prognostic impact of alk amplifications and mutations in the european neuroblastoma study group (siopen) high-risk neuroblastoma trial (hr-nbl1)
Journal of Clinical Oncology, Vol. 39, Núm. 30, pp. 3377-3390
2020
-
Age Dependency of the Prognostic Impact of Tumor Genomics in Localized Resectable MYCN-Nonamplified Neuroblastomas. Report from the SIOPEN Biology Group on the LNESG Trials and a COG Validation Group
Journal of Clinical Oncology, Vol. 38, Núm. 31, pp. 3685-3697
2015
-
Influence of segmental chromosome abnormalities on survival in children over the age of 12 months with unresectable localised peripheral neuroblastic tumours without MYCN amplification
British Journal of Cancer, Vol. 112, Núm. 2, pp. 290-295
2014
-
Neuroblastoma after Childhood: Prognostic Relevance of Segmental Chromosome Aberrations, ATRX Protein Status, and Immune Cell Infiltration
Neoplasia, Vol. 16, Núm. 6, pp. 471-480
2013
2011
-
A multilocus technique for risk evaluation of patients with neuroblastoma
Clinical Cancer Research, Vol. 17, Núm. 4, pp. 792-804